Injectable codeine is accessible for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may result in nonimmune mast-cell degranulation and resulting anaphylactoid reaction. Codeine suppositories may also be marketed in a few international locations. In Eire, new laws arrived into effect on 1 August 2010[90] relating to https://www.codeingil.com/